An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Tekla Life Sciences Investors Declares Distribution
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
On February 15, 2022, Tekla Life Sciences Investors announced a distribution of $0.39 per share, with the record date set for February 25, 2022. The payment date is March 31, 2022, and shares will trade ex-distribution on February 24, 2022. Distribution will typically be issued in newly created shares, valued at the lower of net asset value or market price as of March 23, 2022. Shareholders can opt for cash instead of shares by contacting their broker.
Positive
Declared distribution of $0.39 per share.
Newly issued shares generally provided, maintaining investor engagement.
Negative
None.
BOSTON--(BUSINESS WIRE)--
On February 15, 2022, Tekla Life Sciences Investors declared a distribution of $0.39 per share. The record date for the distribution is February 25, 2022 and the payable date is March 31, 2022. The Fund will trade ex-distribution on February 24, 2022.
This distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. The shares will be valued at the lower of the net asset value or market price on the pricing date, March 23, 2022. Fractional shares will generally be settled in cash, except for registered shareholders with book entry accounts at the transfer agent who will have whole and fractional shares added to their account.
Shareholders may request to be paid in cash instead of shares by responding to the bank, brokerage or nominee who holds the shares if the shares are in “street name” or by filling out an election card received from Computershare Investor Services shortly after the record date if the shares are in registered form. The bank, brokerage or nominee who holds the shares must advise the Depository Trust Company ("DTC") as to their full and fractional share requirements by March 22, 2022. Written notification for the election of cash instead of stock by registered shareholders must be received by Computershare Investor Services prior to March 22, 2022.
Tekla Life Sciences Investors (NYSE: HQL) is a closed-end fund that invests in public and private companies in the life sciences industry. Tekla Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.
For additional information, please consult www.teklacap.com or call 877-855-3434
For additional information, please consult www.teklacap.com or call 877-855-3434
Source: Tekla Life Sciences Investors
FAQ
What is the distribution amount for Tekla Life Sciences Investors (HQL) in 2022?
Tekla Life Sciences Investors declared a distribution of $0.39 per share on February 15, 2022.
When is the record date for the HQL distribution?
The record date for the HQL distribution is February 25, 2022.
When will the distribution for HQL be payable?
The distribution for HQL will be payable on March 31, 2022.
What is the ex-distribution date for Tekla Life Sciences Investors (HQL)?
The ex-distribution date for HQL is February 24, 2022.
How can shareholders choose to receive their HQL distribution?
Shareholders can receive their HQL distribution in cash or newly issued shares by contacting their broker or filling out an election card from Computershare Investor Services.
